Lanreotide Reference

Plain English

What it is

Lanreotide, sold as Somatuline Depot, is an FDA-approved prescription medicine. It is a lab-made copy of somatostatin, a natural body hormone that signals the body to make less growth hormone and fewer gut hormones. A healthcare provider gives it as a deep injection under the skin.

What people use it for

Doctors prescribe it for acromegaly, a condition where the body makes too much growth hormone, and for certain slow-growing tumors of the gut and pancreas known as GEP-NETs. It is also used in adults to ease symptoms of carcinoid syndrome.

What the science shows

It is a standard treatment for these conditions, backed by decades of approved-label evidence. pepSmart shows label-reference information only.

The catch

This is a clinician-administered prescription drug for serious endocrine and tumor conditions, not a research peptide or a fitness aid. Its label warns it can cause gallstones, swings in blood sugar (too high or too low), a slower heart rate, and lower thyroid function, so people taking it are watched closely by their care team.

Reference summary

Lanreotide is a label-verified somatostatin analog with decades of approved-label evidence. pepSmart surfaces label-reference content only.

Regulatory and posture

Categories

Hormonal

Aliases

Somatuline Depot, Somatostatin analog

Evidence posture

human

Regulatory status

FDA-approved prescription medication (Somatuline Depot). Labeled for long-term treatment of acromegaly and for unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Content review status

label verified

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.